What's breaking now, across thousands of outlets.
Experts say India could build on its existing TB diagnostic infrastructure to offer more relevant testing during a single patient visit, although a universal ‘one sample, multiple diseases’ test remains some way off
We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
Benjamin Nworie in Abakaliki The Vice Chancellor of David Umahi Federal University of Health Sciences (DUFUS), Ebonyi State, Professor Jesse Uneke, has said that Nigeria is losing over 600,000 people…
Clinical trial of the Zaire Ebolavirus vaccine Ervebo to be investigated against the current Bundibugyo strain.
As psychedelic therapies expand, new clinics treat uncommon long-term harms
The US president’s executive order calling for scaling back the number of vaccinations American children receive may not have any legal power, but it normalises misinformation about vaccines.
